Theratechnologies Payables Turnover from 2010 to 2024
| THTX Stock | USD 1.24 0.04 3.13% |
Payables Turnover | First Reported 2010-12-31 | Previous Quarter 3.23 | Current Value 5.06 | Quarterly Volatility 5.15421442 |
Check Theratechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theratechnologies main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Total Revenue of 98.7 M or Gross Profit of 75 M, as well as many exotic indicators such as Price To Sales Ratio of 0.56, Dividend Yield of 0.0 or Days Sales Outstanding of 51.65. Theratechnologies financial statements analysis is a perfect complement when working with Theratechnologies Valuation or Volatility modules.
Theratechnologies | Payables Turnover |
Latest Theratechnologies' Payables Turnover Growth Pattern
Below is the plot of the Payables Turnover of Theratechnologies over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. Theratechnologies' Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Theratechnologies' overall financial position and show how it may be relating to other accounts over time.
| Payables Turnover | 10 Years Trend |
|
Payables Turnover |
| Timeline |
Theratechnologies Payables Turnover Regression Statistics
| Arithmetic Mean | 4.75 | |
| Geometric Mean | 3.40 | |
| Coefficient Of Variation | 108.59 | |
| Mean Deviation | 3.11 | |
| Median | 3.18 | |
| Standard Deviation | 5.15 | |
| Sample Variance | 26.57 | |
| Range | 20.8733 | |
| R-Value | (0.50) | |
| Mean Square Error | 21.47 | |
| R-Squared | 0.25 | |
| Significance | 0.06 | |
| Slope | (0.58) | |
| Total Sum of Squares | 371.92 |
Theratechnologies Payables Turnover History
About Theratechnologies Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Theratechnologies income statement, its balance sheet, and the statement of cash flows. Theratechnologies investors use historical funamental indicators, such as Theratechnologies's Payables Turnover, to determine how well the company is positioned to perform in the future. Although Theratechnologies investors may use each financial statement separately, they are all related. The changes in Theratechnologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Theratechnologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Theratechnologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Theratechnologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Payables Turnover | 3.23 | 5.06 |
Currently Active Assets on Macroaxis
When determining whether Theratechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theratechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theratechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theratechnologies Stock:Check out the analysis of Theratechnologies Correlation against competitors. For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Theratechnologies Stock analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Theratechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Theratechnologies. If investors know Theratechnologies will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Theratechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.58) | Revenue Per Share 2.394 | Quarterly Revenue Growth (0.18) | Return On Assets (0.05) | Return On Equity (11.17) |
The market value of Theratechnologies is measured differently than its book value, which is the value of Theratechnologies that is recorded on the company's balance sheet. Investors also form their own opinion of Theratechnologies' value that differs from its market value or its book value, called intrinsic value, which is Theratechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Theratechnologies' market value can be influenced by many factors that don't directly affect Theratechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Theratechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Theratechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theratechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.